NEAT1: A Novel Long Non-coding RNA Involved in Mediating Type 2 Diabetes and its Various Complications

被引:10
作者
Jia, Dengke [1 ]
He, Yaping [1 ]
Wang, Yaqi [1 ]
Xue, Mengzhen [1 ]
Zhu, Leiqi [1 ]
Xia, Fangqi [1 ]
Li, Yuanyang [1 ]
Gao, Yan [1 ]
Li, Luoying [1 ]
Chen, Silong [1 ]
Xu, Guangfu [1 ]
Yuan, Chengfu [1 ,2 ]
机构
[1] China Three Gorges Univ, Coll Med Sci, Yichang 443002, Hubei, Peoples R China
[2] Med Coll China Three Gorges, State Adm Tradit Chinese Med, Third Grade Pharmacol Lab Chinese Med, Yichang 443002, Hubei, Peoples R China
基金
中国国家自然科学基金;
关键词
Long non-coding RNA (LncRNA); NEAT1; diabetes biomarker; molecular mechanism; therapeutic target; fatty liver disease (NAFLD); NLRP3; INFLAMMASOME; POSITION STATEMENT; NEPHROPATHY; INHIBITION; ACTIVATION; MECHANISMS; NEUROPATHY; APOPTOSIS; CELLS;
D O I
10.2174/1381612828666220428093207
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: Nuclear-enriched abundant transcript 1 (abbreviated as NEAT1) is a long-chain non-coding RNA involved in various physiological and pathological processes. This study aimed to clarify the effect and molecule system of NEAT1 within non-alcoholic fatty liver disease (NAFLD) as well as type 2 diabetes (T2DM). Methods: In this review, current studies concerning mechanisms of NEAT1l, in the development of type 2 diabetes and its complications have been summarized and analyzed. Also, we searched the papers based on NEAT1 related to NAFLD. The related studies were obtained through a systematic search of Pubmed. Results: NEAT1 displays a close correlation with how T2DM occurs and develops, and it was confirmed to be significantly up-regulated in T2DM and its various complications (e.g., diabetics nephropathy, diabetics cardiomyopathy, diabetics retinopathy as well as diabetic neuropathy). Besides, NEAT1 is capable of impacting the occurrence, development and prognosis of NAFLD and T2DM. Conclusion: LncRNA NEAT1 is likely to act as a novel therapeutic target for T2DM and its complications. Moreover, non-alcoholic fatty liver disease is also correlated with NEAT1.
引用
收藏
页码:1342 / 1350
页数:9
相关论文
共 66 条
  • [1] Considering gut microbiota in treatment of type 2 diabetes mellitus
    Adeshirlarijaney, Aneseh
    Gewirtz, Andrew T.
    [J]. GUT MICROBES, 2020, 11 (03) : 253 - 264
  • [2] Metabolic Regulation of Adipose Tissue Macrophage Function in Obesity and Diabetes
    Appari, Mahesh
    Channon, Keith M.
    McNeill, Eileen
    [J]. ANTIOXIDANTS & REDOX SIGNALING, 2018, 29 (03) : 297 - 312
  • [3] Determination of the transcriptional level of long non-coding RNA NEAT-1, downstream target microRNAs, and genes targeted by microRNAs in diabetic neuropathy patients
    Asadi, Gelayol
    Varmaziar, Fatemeh Rezaei
    Karimi, Mojgan
    Rajabinejad, Misagh
    Ranjbar, Sedigheh
    Karaji, Ali Gorgin
    Salari, Farhad
    Hezarkhani, Leila Afshar
    Rezaiemanesh, Alireza
    [J]. IMMUNOLOGY LETTERS, 2021, 232 : 20 - 26
  • [4] LNCcation: lncRNA localization and function
    Bridges, Mary Catherine
    Daulagala, Amanda C.
    Kourtidis, Antonis
    [J]. JOURNAL OF CELL BIOLOGY, 2021, 220 (02)
  • [5] Non-alcoholic fatty liver disease and cardiovascular disease: assessing the evidence for causality
    Brouwers, Martijn C. G. J.
    Simons, Nynke
    Stehouwer, Coen D. A.
    Isaacs, Aaron
    [J]. DIABETOLOGIA, 2020, 63 (02) : 253 - 260
  • [6] Diabetic neuropathy: what does the future hold?
    Callaghan, Brian C.
    Gallagher, Gary
    Fridman, Vera
    Feldman, Eva L.
    [J]. DIABETOLOGIA, 2020, 63 (05) : 891 - 897
  • [7] LncRNA NEAT1 promotes hepatic lipid accumulation via regulating miR-146a-5p/ROCK1 in nonalcoholic fatty liver disease
    Chen, Xi
    Tan, Xin-Rui
    Li, Shi-Jun
    Zhang, Xing-Xing
    [J]. LIFE SCIENCES, 2019, 235
  • [8] Osteopontin promotes collagen I synthesis in hepatic stellate cells by miRNA-129-5p inhibition
    Chen, Yinghua
    Ou, Yitao
    Dong, Jiale
    Yang, Guizhi
    Zeng, Zhi
    Liu, Ying
    Liu, Bing
    Li, Weidong
    He, Xiaoshun
    Lan, Tian
    [J]. EXPERIMENTAL CELL RESEARCH, 2018, 362 (02) : 343 - 348
  • [9] Transcriptional control of macrophage polarisation in type 2 diabetes
    Drareni, Karima
    Gautier, Jean-Francois
    Venteclef, Nicolas
    Alzaid, Fawaz
    [J]. SEMINARS IN IMMUNOPATHOLOGY, 2019, 41 (04) : 515 - 529
  • [10] MiR-146a-5p suppresses activation and proliferation of hepatic stellate cells in nonalcoholic fibrosing steatohepatitis through directly targeting Wnt1 and Wnt5a
    Du, Jinghua
    Niu, Xuemin
    Wang, Yang
    Kong, Lingbo
    Wang, Rongqi
    Zhang, Yuguo
    Zhao, Suxian
    Nan, Yuemin
    [J]. SCIENTIFIC REPORTS, 2015, 5